GLP-1s support weight loss by: Delaying gastric emptying, which helps you feel fuller for longer after meals Regulating blood sugar, which can support steady energy and fewer cravings Reducing appetite and food noise by acting on hunger-regulating areas of the brain While Ozempic, Wegovy, Foundayo, and Zepbound all fall under the GLP-1 umbrella, Zepbound is unique in that it also targets another hormone called GIP (glucose-dependent insulinotropic polypeptide)
Acid labile linkers are compatible with a wide range of payloads, including small molecule cytotoxins (e.g., DM1, MMAE), radioactive labels, and nucleic acid drugs
I., Poprzeczny, A., Mazza, D., & Grzeskowiak, L
5 NonHabitForming Support vs
Retatrutide Clinical Trials & Results Last updated: August 1, 2026 Retatrutide (LY3437943) is Eli Lilly's investigational triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors